Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Quinn
Prm46 - Measuring and Analysing the Maturity of Overall Survival Data for Treatments for Relapsed or Refractory Multiple Myeloma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Carfilzomib for Relapsed or Refractory Multiple Myeloma
The Lancet Oncology
Oncology
Bendamustine, Pomalidomide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma
European Journal of Medical Research
Medicine
Optimizing the Use of Lenalidomide in Relapsed or Refractory Multiple Myeloma: Consensus Statement
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Prm272 - The Eunethta Transferability Tool: Application to Novel Treatments for Relapsed Refractory Multiple Myeloma in the Irish Healthcare Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatments for Newly Diagnosed Multiple Myeloma: Analysis of Survival Data and Cost-Effectiveness Evaluation.
Oncology Reports
Medicine
Cancer Research
Oncology
Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin With Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
Cancer
Cancer Research
Oncology
Thalidomide Versus Dexamethasone for the Treatment of Relapsed and/or Refractory Multiple Myeloma: Results From OPTIMUM, a Randomized Trial
Haematologica
Hematology
Pcn311 - European Market Access Challenges for Relapsed Refractory Multiple Myeloma Triplet Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
